Meeting NewsVideo

VIDEO: BOULEVARD trial advances molecule for treatment of DME

VANCOUVER, British Columbia — At the American Society of Retina Specialists annual meeting, Rishi P. Singh, MD, discusses findings from the BOULEVARD trial, which he said validated the signal of RG7716 (Genentech/Roche) as a potential molecule for the treatment of diabetic macular edema and demonstrated the agent’s “superiority to currently available therapeutics” as well as potential increased durability over time.

VANCOUVER, British Columbia — At the American Society of Retina Specialists annual meeting, Rishi P. Singh, MD, discusses findings from the BOULEVARD trial, which he said validated the signal of RG7716 (Genentech/Roche) as a potential molecule for the treatment of diabetic macular edema and demonstrated the agent’s “superiority to currently available therapeutics” as well as potential increased durability over time.

    See more from American Society of Retina Specialists Meeting